Approval · Notice of Compliance 9537 · 2008
ZANAFLEX: Notice of Compliance 9537
Issued May 1, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9537
- Date
- May 1, 2008
- Company
- Squire Pharmaceuticals Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antispastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANAFLEX | 02245328 | — |
| ZANAFLEX | 02239170 | Cancelled Post Market |
Medicinal ingredients
- TIZANIDINE HCL 2 MG per TAB
- TIZANIDINE HCL 4 MG per TAB